Protective immunity following vaccination: How is it defined?, Human Vaccines, vol.4, issue.4, pp.316-319, 2008. ,
DOI : 10.4161/hv.4.4.5751
URL : http://www.tandfonline.com/doi/pdf/10.4161/hv.4.4.5751?needAccess=true
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys, Nature, vol.86, pp.224-228 ,
DOI : 10.1128/JVI.00644-12
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity, EBioMedicine, vol.12, pp.196-207 ,
DOI : 10.1016/j.ebiom.2016.08.045
Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism, Journal of Medical Virology, vol.15, issue.3, pp.256-263, 1999. ,
DOI : 10.1093/infdis/173.1.60
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection, AIDS, vol.12, issue.13, pp.1591-1600, 1998. ,
DOI : 10.1097/00002030-199813000-00005
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117, Nature, vol.14, issue.7557, pp.487-491, 2015. ,
DOI : 10.1101/gr.849004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890714
A Longitudinal Study of Neutralizing Antibodies and Disease Progression in HIV???1???Infected Subjects, The Journal of Infectious Diseases, vol.179, issue.6, pp.1365-1374, 1999. ,
DOI : 10.1086/314773
Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection, PLoS ONE, vol.7, issue.8, p.44163, 2012. ,
DOI : 10.1371/journal.pone.0044163.t004
A proteomics approach for the identification and cloning of monoclonal antibodies from serum, Nature Biotechnology, vol.82, issue.5, pp.447-452, 2012. ,
DOI : 10.1073/pnas.92.16.7297
Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables, Journal of Virology, vol.84, issue.3, pp.1631-1636, 2010. ,
DOI : 10.1128/JVI.01482-09
Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment, Journal of Virology, vol.79, issue.22, pp.14169-14178, 2005. ,
DOI : 10.1128/JVI.79.22.14169-14178.2005
Cross???Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression, The Journal of Infectious Diseases, vol.201, issue.7, pp.1045-1053, 2010. ,
DOI : 10.1086/651144
URL : https://academic.oup.com/jid/article-pdf/201/7/1045/18061264/201-7-1045.pdf
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller, Science Translational Medicine, vol.60, issue.373, 2017. ,
DOI : 10.2144/000113370
The HIV Env-mediated fusion reaction, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1614, issue.1, pp.36-50, 2003. ,
DOI : 10.1016/S0005-2736(03)00161-5
URL : http://doi.org/10.1016/s0005-2736(03)00161-5
Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors, Journal of Virology, vol.84, issue.7, pp.3576-3585, 2010. ,
DOI : 10.1128/JVI.02622-09
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV, AIDS, vol.23, issue.9, pp.1163-1169, 1999. ,
DOI : 10.1097/QAD.0b013e32832b44c8
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II, PLoS ONE, vol.139, issue.5, p.36438, 2012. ,
DOI : 10.1371/journal.pone.0036438.s006
Involvement of Fc??R I (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified from Infected Patients in Cultured Monocyte-Derived Macrophages, The Journal of Immunology, vol.173, issue.10, pp.6274-6283, 2004. ,
DOI : 10.4049/jimmunol.173.10.6274
Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells, Journal of Virology, vol.80, issue.12, pp.6177-6181, 2006. ,
DOI : 10.1128/JVI.02625-05
URL : http://jvi.asm.org/content/80/12/6177.full.pdf
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection, AIDS, vol.28, issue.2, pp.163-169, 2014. ,
DOI : 10.1097/QAD.0000000000000106
Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses, Frontiers in Immunology, vol.4, p.58, 2013. ,
DOI : 10.3389/fimmu.2013.00058
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2013.00058/pdf
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1, Journal of Virology, vol.77, issue.19, pp.10557-10565, 2003. ,
DOI : 10.1128/JVI.77.19.10557-10565.2003
Impact of Suppression of Viral Replication by Highly Active Antiretroviral Therapy on Immune Function and Phenotype in Chronic HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.30, issue.1, 2002. ,
DOI : 10.1097/00042560-200205010-00005
Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers, Journal of Virology, vol.88, issue.1, pp.176-187, 2014. ,
DOI : 10.1128/JVI.02098-13
Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an Fc??RIIa Independent Mechanism and Do Not Diminish Cytokines Production, Scientific Reports, vol.75, issue.1, p.5845, 2014. ,
DOI : 10.1128/JVI.75.11.5421-5424.2001
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer, Science, vol.53, issue.3, pp.1043-1048, 2016. ,
DOI : 10.1016/0304-3991(94)90038-8
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development, Proceedings of the National Academy of Sciences, vol.88, issue.13, pp.15614-15621, 2014. ,
DOI : 10.1128/JVI.00728-14
URL : http://www.pnas.org/content/111/44/15614.full.pdf
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus, Science, vol.73, issue.6303, pp.1045-1049 ,
DOI : 10.1038/nm833
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo, Science, vol.274, issue.5289, pp.1001-1004, 2016. ,
DOI : 10.1126/science.274.5289.985
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-in- fected individuals, Blood, vol.93, pp.936-941, 1999. ,
Combination of HIV???1???Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long???Term Nonprogression, The Journal of Infectious Diseases, vol.191, issue.12, pp.2053-2063, 2005. ,
DOI : 10.1086/430320
High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation, Proc. Natl. Acad. Sci. U. S. A. 98, pp.13878-13883, 2001. ,
DOI : 10.1126/science.277.5322.112
Success and failure of the cellular immune response against HIV-1, Nature Immunology, vol.72, issue.6, pp.563-570, 2015. ,
DOI : 10.1126/science.1237874
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1, PLoS Pathogens, vol.21, issue.1, 2011. ,
DOI : 10.1371/journal.ppat.1001251.s004
Structure and immune recognition of trimeric pre-fusion HIV-1 Env, Nature, vol.208, issue.7523, pp.455-461 ,
DOI : 10.1084/jem.20101907
Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41, Journal of Virology, vol.83, issue.15, pp.7397-7410, 2009. ,
DOI : 10.1128/JVI.00656-09
Antibody-DEPENDENT, Fc?RI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis, 2013. ,
A Single Amino-Acid Change in a Highly Conserved Motif of gp41 Elicits HIV-1 Neutralization and Protects Against CD4 Depletion, Clinical Infectious Diseases, vol.57, issue.5, pp.745-755, 2013. ,
DOI : 10.1093/cid/cit335
Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression, Journal of Virology, vol.83, issue.19, pp.10269-10274, 2009. ,
DOI : 10.1128/JVI.01149-09
Polymorphism of gp41 glycoprotein might influence the progression to disease in HIV-1 infection, AIDS, vol.27, issue.7, pp.1189-1191, 2013. ,
DOI : 10.1097/QAD.0b013e32835f6b30
Human Immunodeficiency Virus (HIV)-Positive Sera Obtained Shortly after Seroconversion Neutralize Autologous HIV Type 1 Isolates on Primary Macrophages but Not on Lymphocytes, Journal of Virology, vol.74, issue.12, pp.5403-5411, 2000. ,
DOI : 10.1128/JVI.74.12.5403-5411.2000
URL : http://jvi.asm.org/content/74/12/5403.full.pdf
Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design, Annual Review of Medicine, vol.67, issue.1, pp.185-200, 2016. ,
DOI : 10.1146/annurev-med-091014-090749
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group Proc. Natl. Acad. Sci. U. S. A. 104, pp.6776-6781, 2007. ,
DOI : 10.1002/biot.200600045
Broadly Neutralizing Antibodies for HIV Eradication, Current HIV/AIDS Reports, vol.211, issue.236, pp.31-37, 2016. ,
DOI : 10.1084/jem.20141050
URL : https://link.springer.com/content/pdf/10.1007%2Fs11904-016-0299-7.pdf
Which Antibody Functions are Important for an HIV Vaccine?, Frontiers in Immunology, vol.10, issue.Suppl 2, p.289, 2014. ,
DOI : 10.1186/1479-5876-10-144
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00289/pdf
NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand, Proceedings of the National Academy of Sciences, vol.387, issue.6631, pp.10981-10986, 2005. ,
DOI : 10.1038/387426a0
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection, AIDS, vol.20, issue.14, pp.1795-1804, 2006. ,
DOI : 10.1097/01.aids.0000244198.65263.17
URL : http://pdfs.journals.lww.com/aidsonline/2006/09110/Specific_adaptive_humoral_response_against_a_gp41.2.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503338647285;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdN2ziiHhY6wPF9tfA80junpwhe3BgTIW8MAzFJzgZ93A=;hash|Z2aLQFRoC/qrTuZXWIgAkw==
A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques, Proceedings of the National Academy of Sciences, vol.80, issue.1, pp.2100-2104, 2008. ,
DOI : 10.1128/JVI.80.1.236-245.2006
An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques, Vaccine, vol.30, issue.48, pp.6883-6891, 2012. ,
DOI : 10.1016/j.vaccine.2012.09.004
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?, Oncotarget, vol.7, issue.25, pp.38946-38958, 2016. ,
DOI : 10.18632/oncotarget.7793
URL : https://hal.archives-ouvertes.fr/hal-01285657
Structural insights on the role of antibodies in HIV-1 vaccine and therapy, Cell, vol.156, pp.633-648, 2014. ,
Lineage relationship and protective immunity of memory CD8 T cell subsets, Nature Immunology, vol.4, issue.3, pp.225-234, 2003. ,
DOI : 10.1038/ni889
Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response, Proc. Natl. Acad. Sci. U. S. A. 110, pp.2993-2998, 2013. ,
DOI : 10.1074/mcp.M900540-MCP200
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens, Science, vol.280, issue.5371, pp.1884-1888, 1998. ,
DOI : 10.1126/science.280.5371.1884
ALT-ANRS-CO15 study group, 2010. Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control, AIDS, vol.24, pp.2323-2329 ,
Diversity in the CDR3 Region of VH Is Sufficient for Most Antibody Specificities, Immunity, vol.13, issue.1, pp.37-45, 2000. ,
DOI : 10.1016/S1074-7613(00)00006-6
Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1, Frontiers in Immunology, vol.340, issue.Suppl, p.250, 2014. ,
DOI : 10.1126/science.1234150
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00250/pdf
Plasmas from Lymphocyte- and Macrophage-Tropic SIVmac-Infected Macaques Have Antibodies with a Broader Spectrum of Virus Neutralization Activity in Macrophage versus Lymphocyte Cultures, Virology, vol.227, issue.1, pp.24-33, 1997. ,
DOI : 10.1006/viro.1996.8300